Review: Current evidence shows no overall benefit of aspirin for primary prevention of cardiovascular disease in diabetes

LeFevre, Michael
April 2010
ACP Journal Club;4/20/2010, Vol. 152 Issue 4, p9
Academic Journal
The article presents information on the study undertaken to find if aspirin is beneficial for primary prevention of cardiovascular disease in diabetes. The study involved searching the various databases for randomized controlled trials with more than 500 participants. The result shows the aspirin is no beneficial effect for prevention of cardiovascular diseases. Also charts and discussion of the result are presented.


Related Articles

  • CLINICAL TRIAL DIGEST.  // Pulmonary Reviews;May2011, Vol. 16 Issue 5, p7 

    A table is presented that shows the results of randomized controlled experiments including the use of Atorvastatin 20 milligram (mg) or placebo for severe infection, the application of three-monthly spirometry with medical study or spirometry before and after the test, or normal care for the...

  • Multinational, double-blind, randomised, placebocontrolled, prospective study of esomeprazole in the prevention of recurrent peptic ulcer in low-dose acetylsalicylic acid users: the LAVENDER* study. Kentaro Sugano; Myung-Gyu Choi; Jaw-Town Lin; Shinya Goto; Yasushi Okada; Yoshikazu Kinoshita; Hiroto Miwa; Chern-En Chiang; Tsutomu Chiba; Masatsugu Hori; Yasushi Fukushima; Hyun-Soo Kim; Chi-Yang Chang; Masataka Date // Gut;Jul2014, Vol. 63 Issue 7, p1061 

    Objectives To evaluate if esomeprazole prevents recurrent peptic ulcer in adult patients with a history of peptic ulcer receiving low-dose acetylsalicylic acid (ASA, aspirin) for cardiovascular protection in East Asia. Methods In this prospective, randomised, double-blind, placebo-controlled...

  • Benefits of nurse-led cardiovascular prevention for patients with type 1 diabetes. Voogdt-Pruis, Helene; Vrijhoef, H. J. M.; Beusmans, G. H. M. I. // Evidence Based Nursing;Oct2011, Vol. 14 Issue 4, p104 

    An abstract of the article "Nurse-led cardiovascular risk factor intervention leads to improvements in cardiovascular risk targets and glycaemic control in people with type 1 diabetes when compared with routine diabetes clinic attendance," by M. E. Wallymahmed and colleagues is presented.

  • Cardiovascular and mortality benefits of statin therapy exceed the diabetes hazard. Thomas, Jack // Australian Journal of Pharmacy;Dec2012, Vol. 93 Issue 1111, p75 

    The article offers information on a randomized and doubleblind JUPITER trial conducted to 17,603 men and women with no history of cardiovascular disease or diabetes. The participants of the study were stratified on the basis of having none or at least one of four major risk factors for diabetes...

  • Aspirin for Primary Prevention of Cardiovascular Events in Diabetes. Colwell, John A. // Diabetes Care;Dec2003, Vol. 26 Issue 12, p3349 

    Focuses on the use of aspirin for primary prevention of cardiovascular events in diabetes. Inhibition of the enzyme that converts arachidonic acid to prostaglandins by very low doses of aspirin; Risks of myocardial infarction, stroke and cardiovascular death in people with type 2 diabetes;...

  • 2012 - Individual-patient meta-analysis: Daily aspirin reduces risk for incident cancer with distant metastasis. Diehl, Andrew K. // ACP Journal Club;7/17/2012, Vol. 157 Issue 2, p1 

    The article reports that regular use of aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs) can reduce the occurrence of colorectal cancer and decrease associated mortality. It discusses a meta analysis study which suggests beneficial effects of NSAIDs during its long term use on control of...

  • Aspirin in Primary Prevention of Cardiovascular Disease and Cancer: A Systematic Review of the Balance of Evidence from Reviews of Randomized Trials. Sutcliffe, Paul; Connock, Martin; Gurung, Tara; Freeman, Karoline; Johnson, Samantha; Ngianga-Bakwin, Kandala; Grove, Amy; Gurung, Binu; Morrow, Sarah; Stranges, Saverio; Clarke, Aileen // PLoS ONE;Dec2013, Vol. 8 Issue 12, p1 

    Background:Aspirin has been recommended for primary prevention of cardiovascular disease (CVD) and cancer, but overall benefits are unclear. We aimed to use novel methods to re-evaluate the balance of benefits and harms of aspirin using evidence from randomised controlled trials, systematic...

  • Low Carbohydrate versus Isoenergetic Balanced Diets for Reducing Weight and Cardiovascular Risk: A Systematic Review and Meta-Analysis. Naude, Celeste E.; Schoonees, Anel; Senekal, Marjanne; Young, Taryn; Garner, Paul; Volmink, Jimmy // PLoS ONE;Jul2014, Vol. 9 Issue 7, p1 

    Background: Some popular weight loss diets restricting carbohydrates (CHO) claim to be more effective, and have additional health benefits in preventing cardiovascular disease compared to balanced weight loss diets. Methods and Findings: We compared the effects of low CHO and isoenergetic...

  • Aspirin for the Primary Prevention of Cardiovascular Events. Calvin, Andrew D.; Aggarwal, Niti R.; Murad, Mohammad Hassan; Shi, Qian; Elamin, Mohamed B.; Geske, Jeffrey B.; Fernandez-Balsells, M. Merce; Albuquerque, Felipe N.; Lampropulos, Julianna F.; Erwin, Patricia J.; Smith, Steven A.; Montori, Victor M. // Diabetes Care;Dec2009, Vol. 32 Issue 12, p2300 

    OBJECTIVE -- The negative results of two randomized controlled trials (RCTs) have challenged current guideline recommendations for using aspirin for primary prevention of cardiovascular events among patients with diabetes. We therefore sought to determine if the effect of aspirin for primary...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics